All Comments by Lars Lannfelt
Go to another page:
- 1
- 2
- Sylvain Lesné, Who Found Aβ*56, Accused of Image Manipulation
- Field Loses GSM Developer Steven Wagner, 64
- In Familial AD, Amyloid-PET Varies by Mutation Type; CSF Aβ42 Doesn't
- Cryo-EM Unveils Distinct Aβ42 Fibril Structures for Sporadic, Familial AD
- Does Anti-Amyloid Immunotherapy Need the Lymphatic System?
- Of Four Aβ Antibodies, Only Aducanumab Stems Tide of Toxic Oligomers
- Molecular Transport Vehicle Shuttles Therapies into Brain
- BAN2401 Removes Brain Amyloid, Possibly Slows Cognitive Decline
- New Definition of Alzheimer’s Hinges on Biology, Not Symptoms
- Sweat the Small Stuff: Teeniest Aβ Oligomers Wreak Most Havoc
- Dale Schenk, 59, Pioneer of Alzheimer’s Immunotherapy
- NIH Director Announces $100M Prevention Trial of Genentech Antibody
- Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease.
- High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients.
- San Diego: Oligomers Live Up to Bad Reputation, Part 1